Tenon Medical (TNON) Projected to Post Earnings on Tuesday

Tenon Medical (NASDAQ:TNON) is expected to issue its Q1 2026 results after the market closes on Tuesday, May 12th. Analysts expect the company to announce earnings of ($0.3050) per share and revenue of $1.2960 million for the quarter. Interested persons may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Tuesday, May 12, 2026 at 4:30 PM ET.

Tenon Medical (NASDAQ:TNON) last announced its quarterly earnings data on Thursday, March 19th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.36) by $0.14. Tenon Medical had a negative return on equity of 409.16% and a negative net margin of 318.36%.The company had revenue of $1.48 million during the quarter, compared to analysts’ expectations of $1.38 million.

Tenon Medical Stock Performance

NASDAQ:TNON traded up $0.00 during mid-day trading on Tuesday, hitting $0.76. The stock had a trading volume of 11,308 shares, compared to its average volume of 766,339. Tenon Medical has a twelve month low of $0.64 and a twelve month high of $2.48. The stock has a market cap of $8.55 million, a price-to-earnings ratio of -0.38 and a beta of 1.28. The company’s 50 day simple moving average is $0.79 and its 200 day simple moving average is $0.95.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Tenon Medical in a research report on Monday, April 20th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold”.

Institutional Trading of Tenon Medical

Hedge funds and other institutional investors have recently modified their holdings of the stock. Jane Street Group LLC acquired a new position in shares of Tenon Medical during the first quarter worth $29,000. Geode Capital Management LLC lifted its holdings in shares of Tenon Medical by 34.6% during the fourth quarter. Geode Capital Management LLC now owns 66,640 shares of the company’s stock worth $63,000 after purchasing an additional 17,137 shares during the period. Finally, DRW Securities LLC acquired a new position in Tenon Medical in the fourth quarter valued at $98,000. Institutional investors own 22.74% of the company’s stock.

About Tenon Medical

Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.

Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.